BioCardia, Inc. Sale of Stock, Price Per Share
BioCardia, Inc. (BCDA) had Sale of Stock, Price Per Share of $6.75 per share as of 2018-12-24, per its 10-K filed 2021-03-30.
Discontinued › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2021-03-30
- 2018-12-24: Sale of Stock, Price Per Share $6.75; Sale of Stock, Price Per Share as first filed $0.75.
| Period end | Sale of Stock, Price Per Share | Sale of Stock, Price Per Share as first filed |
|---|---|---|
| 2018-12-24 | $6.75 10-K · filed 2021-03-30 | $0.75 10-K · filed 2019-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |